These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9308246)

  • 21. Normal and neoplastic B cell development in the bursa of fabricius.
    Thompson CB; Challoner PB; Neiman PE
    Curr Top Microbiol Immunol; 1986; 132():209-14. PubMed ID: 3024913
    [No Abstract]   [Full Text] [Related]  

  • 22. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas.
    Vrzalikova K; Woodman CB; Murray PG
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):1-6. PubMed ID: 22580854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.
    Haupt Y; Bath ML; Harris AW; Adams JM
    Oncogene; 1993 Nov; 8(11):3161-4. PubMed ID: 8414519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation.
    Auersperg N; Roskelley C
    Crit Rev Oncog; 1991; 2(2):125-60. PubMed ID: 1854833
    [No Abstract]   [Full Text] [Related]  

  • 26. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.
    Young KH; Xie Q; Zhou G; Eickhoff JC; Sanger WG; Aoun P; Chan WC
    Am J Clin Pathol; 2008 Jan; 129(1):157-66. PubMed ID: 18089500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.
    Jeong D; Kim J; Nam J; Sun H; Lee YH; Lee TJ; Aguiar RC; Kim SW
    Leukemia; 2015 Sep; 29(9):1868-74. PubMed ID: 25915824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.
    Rosenthal A; Younes A
    Blood Rev; 2017 Mar; 31(2):37-42. PubMed ID: 27717585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch signaling suppresses IgH gene expression in chicken B cells: implication in spatially restricted expression of Serrate2/Notch1 in the bursa of Fabricius.
    Morimura T; Miyatani S; Kitamura D; Goitsuka R
    J Immunol; 2001 Mar; 166(5):3277-83. PubMed ID: 11207282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
    Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
    Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transforming activity of PP59C-MYC is weaker than that of v-myc.
    Humphries EH; Filardo EJ
    Curr Top Microbiol Immunol; 1990; 166():259-65. PubMed ID: 2073806
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular biology of malignant lymphomas for non-specialists].
    Novak U
    Ther Umsch; 2010 Oct; 67(10):501-4. PubMed ID: 20886455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.
    Sewastianik T; Prochorec-Sobieszek M; Chapuy B; Juszczyński P
    Biochim Biophys Acta; 2014 Dec; 1846(2):457-67. PubMed ID: 25199984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of a chicken B-cell lymphoma by suppressor T-cells from agammaglobulinemic chickens.
    Chi DS; Sharma JM
    Anticancer Res; 1990; 10(5A):1347-51. PubMed ID: 2146919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocked B cell differentiation and emigration support the early growth of Myc-induced lymphomas.
    Brandvold KA; Ewert DL; Kent SC; Neiman P; Ruddell A
    Oncogene; 2001 May; 20(25):3226-34. PubMed ID: 11423972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in pathological understanding of high-grade B cell lymphomas.
    Li S; Lin P; Medeiros LJ
    Expert Rev Hematol; 2018 Aug; 11(8):637-648. PubMed ID: 29989509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bumper crop of cancer genes.
    DePinho RA; Jacks T
    Nat Genet; 1999 Nov; 23(3):253-4. PubMed ID: 10545932
    [No Abstract]   [Full Text] [Related]  

  • 40. Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.
    Song L; Zlobin A; Ghoshal P; Zhang Q; Houde C; Weijzen S; Jiang Q; Nacheva E; Yagan D; Davis E; Galiegue-Zouitina S; Catovsky D; Grogan T; Fisher RI; Miele L; Coignet LJ
    Cancer Res; 2005 Jun; 65(11):4554-61. PubMed ID: 15930272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.